A Phase 2 Study to Evaluate the Safety, PK, and Exploratory PD of Tildacerfont in Children With CAH

  • End date
    Jun 22, 2023
  • participants needed
  • sponsor
    Spruce Biosciences
Updated on 22 July 2022


An investigation of the safety of Tildacerfont in pediatric subjects with CAH.


This is a study to evaluate the safety of Tildacerfont in pediatric subjects with CAH. Treatment will consist of 14 days of continuous dosing followed by safety follow up.

Condition Congenital Adrenal Hyperplasia, 21-OHD
Treatment Tildacerfont
Clinical Study IdentifierNCT05128942
SponsorSpruce Biosciences
Last Modified on22 July 2022


Yes No Not Sure

Inclusion Criteria

Male and female subjects aged 6 to 17 years
Diagnosis of CAH due to 21-OHD and/or elevated 17-OHP requiring ongoing GC replacement since diagnosis
Stable dose of GC replacement for at least 1 month prior to screening

Exclusion Criteria

CAH not due to 21-OHD
History of bilateral adrenalectomy or hypopituitarism
Current treatment with dexamethasone
Clinically significant unstable medical conditions, illness, or chronic diseases
History of active bleeding disorders
Females who are pregnant or nursing
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note